Abstract
Purpose
To assess the reproducibility of the dose–volume distribution of the initial simulation CT, generated using volumetric modulated arc therapy (VMAT) planning, during the radiotherapy of the prostatic bed based on weekly cone beam CTs (CBCT).
Methods
Twenty-three patients, after radical prostatectomy were treated with adjuvant or salvage radiotherapy between July and December 2016 and considered for this evaluation. Weekly CBCT scans (n = 138) were imported into the treatment planning system, and the clinical tumor volume (CTV), the rectum and the bladder were contoured. The initially calculated dose distribution and the dose–volume histograms generated from weekly CBCTs were compared. The prostatic fossa dose coverage was assessed by the proportion of the CTV fully encompassed by the 95% and 98% isodose lines. Rectal and bladder volumes receiving 50, 60 and 65 Gy during the treatment were compared to the initial plan, with statistical significance determined using the one-sample t‑test.
Results
Marked variations in the total organ volume of the rectum and the bladder were observed. The correlation between rectum volume and V50 was not significant (p = 0.487), while the bladder volume and V50 demonstrated a significant correlation. There was no correlation between urinary bladder volume and CTV. The change in rectal volume correlated significantly with CTV. The dose coverage (D98% and D95%) to the prostatic bed could be achieved for all patients due to the ventral shift in the volume differences of the rectum.
Conclusion
Weekly CBCTs can be considered as adequate verification tools to assess the interfractional variability of the CTV and organs at risk. The proven volume changes in the urinary bladder and the rectum do not compromise the final delivered dose in the CTV.
Zusammenfassung
Zielsetzung
Die Bewertung der Reproduzierbarkeit der Dosis-Volumen-Belastung nach computertomographisch gestützter volumetrischer Bogenbestrahlung(VMAT)-Planung im Therapieverlauf basierend auf wöchentlichen „cone beam CTs“ (CBCT).
Methoden
Es wurden 23 Patienten einbezogen, bei denen nach radikaler Prostatektomie zwischen Juli 2016 und Dezember 2016 eine adjuvante oder Salvage-Radiotherapie zum Einsatz kam. Wöchentlich angefertigte CBCTs (n = 138) wurden in das Planungssystem importiert und das CTV („clinical target volume“), das Rektum und die Harnblase konturiert. Auf Basis der initial berechneten Dosisverteilung wurden die zeitabschnittsbezogenen Dosis-Volumen-Belastungen verglichen. Die Bewertung der Dosisverordnung in der Prostataloge erfolgte anhand der 98%- bzw. 95%-Dosis-Volumenabdeckung. Für die Bewertung der Rektum- und Harnblasenbelastung dienten V50, V60 und V65. Signifikante Differenzen wurden mit dem Einstichproben-t-Test ermittelt.
Ergebnisse
Es gab deutliche Variationen der Organvolumina von Rektum und Harnblase. Die Korrelation zwischen den Rektumvolumina und der entsprechenden V50 waren nicht signifikant (p = 0,49), jedoch zeigte das Harnblasenvolumen zur entsprechenden V50 eine signifikante Korrelation. Es gab keine Korrelation von Harnblasenvolumen zu CTV. Die Veränderung des Rektumvolumens korrelierte signifikant mit dem CTV. Durch die Ventralausrichtung der Volumendifferenz des Rektums konnte die Dosisverschreibung (D98% und D95%) an der Prostataloge bei allen Patienten realisiert werden.
Schlussfolgerung
Wöchentliche CBCTs sind ein adäquates Verifikationstool zur Bewertung der interfraktionellen Organvariabilität von CTV und Risikoorganen. Die nachgewiesenen Volumenveränderungen an Harnblase und Rektum kompromittieren die Dosisverordnung im CTV nicht. Die nachgewiesenen Volumenveränderungen an Harnblase und Rektum kompromittieren nicht die Dosisverordnung im CTV.
Similar content being viewed by others
Abbreviations
- CBCT:
-
Cone-beam computed tomography
- CTV:
-
Clinical target volume
- IMRT:
-
Intensity modulated radiotherapy
- PTV:
-
Planned target volume
- OAR:
-
Organs at risk
- RT:
-
Radiotherapy
- VMAT:
-
Volumetric modulated arc therapy
- ICRU:
-
International Commission on Radiation Units and Measurements
- DVH:
-
Dose–volume histogram
- DWH:
-
Dose–wall histogram
- DSH:
-
Dose–surface histogram
- QUANTEC:
-
Quantitative Analysis of Normal Tissue Effects in the Clinic
- EORTC:
-
European Organisation for Research and Treatment of Cancer
- RTOG:
-
Radiation Therapy Oncology Group
References
Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED (2009) Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term follow up of a randomized clinical trial. J Urol 181(3):956–962
Wiegel T, Bartkowiak D, Bottke D et al (2014) Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial. Eur Urol 66:243–250
Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Maréchal JM, Scalliet P, Haustermans K, Piérart M (2005) European Organization for Research and Treatment of Cancer. Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet 366(9485):572–578
Choo R, Hruby G, Hong J, Hong E, DeBoer G, Danjoux C et al (2002) Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: To irradiate or not? Int J Radiat Oncol Biol Phys 52(3):674–680
Cozzarini C, Bolognesi A, Ceresoli GL, Fiorino C, Rossa A, Bertini R et al (2004) Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: A single institute experience of 415 patients. Int J Radiat Oncol Biol Phys 59(3):674–683
Cozzarini C, Fiorino C, Mandelli D, Campagnoli E, Fallini M, Reni M et al (2000) 3D conformal radiotherapy significantly reduces toxicity of post-prostatectomy adjuvant of salvage irradiation. Int J Radiat Oncol Biol Phys 48(3):248
Pearlstein KA, Chen RC (2013) Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensitymodulated, and proton radiation therapy for prostate cancer. Semin Radiat Oncol 23:182–190
Alongi F, Fogliata A, Navarria P, Tozzi A, Mancosu P, Lobefalo F, Reggiori G, Clivio A, Cozzi L, Scorsetti M (2012) Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer. Report of feasibility and acute toxicity. Strahlenther Onkol 188:990–996
Cozzarini C, Fiorino C, Di Muzio N, Alongi F, Broggi S, Cattaneo M, Montorsi F, Rigatti P, Calandrino R, Fazio F (2007) Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer. Radiother Oncol 84:164–170
Otto K (2008) Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 35(1):310–317
Huang K, Palma DA, Scott D et al (2012) Inter- and intrafraction uncertainty in prostate bed image-guided radiotherapy. Int J Radiat Oncol Biol Phys 84:402–407
Klayton T, Price R, Buyyounouski MK, Sobczak M, Greenberg R, Li J, Keller L, Sopka D, Kutikov A, Horwitz EM (2012) Prostate bed motion during intensity-modulated radiotherapy treatment. Int J Radiat Oncol Biol Phys 84:130–136
Verma V, Chen S, Zhou S et al (2016) Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails. Strahlenther Onkol 193(1):38–45
Alongi F, Di Muzio N (2009) Image-guided radiation therapy: A new era for the radiation oncologist? Int J Clin Oncol 14:568–569
Schulze D, Liang J, Yan D, Zhang T (2009) Comparison of various online IGRT strategies: The benefits of online treatment plan re-optimization. Radiother Oncol 90(3):367–376
Rudat V, Nour A, Hammoud M, Alaradi A, Mohammed A (2016) Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity. Strahlenther Onkol 192:109–117
Wang W, Wu Q, Yan D (2010) Quantitative evaluation of cone-beam computed tomography in target volume definition for offline image-guided radiation therapy of prostate cancer. Radiother Oncol 94(1):71–75
Lei Y, Wu Q (2010) A hybrid strategy of offline adaptive planning and online image guidance for prostate cancer radiotherapy. Phys Med Biol 55(8):2221
Onozato Y, Kadoya N, Fujita Y, Arai K, Dobashi S, Takeda K et al (2013) Evaluation of on-board kV cone beam CT-based dose calculation using deformable image registration and modification of HU values. Int J Radiat Oncol Biol Phys 87(2):711–712
Marchant TE, Moore CJ, Rowbottom CG, Mackay RI, Williams PC (2008) Shading correction algorithm for improvement of cone-beam CT images in radiotherapy. Phys Med Biol 53(20):5719
Kupelian PA, Langen KM, Zeidan OA, Meeks SL, Willoughby TR, Wagner TH et al (2006) Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 66(3):876–882
Langen KM, Lu W, Willoughby TR, Chauhan B, Meeks SL, Kupelian PA et al (2009) Dosimetric effect of prostate motion during helical tomotherapy. Int J Radiat Oncol Biol Phys 74(4):1134–1142
Pawlowski JM, Yang ES, Malcolm AW, Coffey CW, Ding GX (2010) Reduction of dose delivered to organs at risk in prostate cancer patients via image-guided radiation therapy. Int J Radiat Oncol Biol Phys 76(3):924–934
Sripadam R, Stratford J, Henry AM, Jackson A, Moore CJ, Price P (2009) Rectal motion can reduce CTV coverage and increase rectal dose during prostate radiotherapy: A daily cone-beam CT study. Radiother Oncol 90(3):312–317
Guckenberger M, Meyer J, Baier K, Vordermark D, Flentje M (2006) Distinct effects of rectum delineation methods in 3D-confromal vs. IMRT treatment planning of prostate cancer. Radiat Oncol 1(1):34
Hatton JA, Greer PB, Tang C, Wright P, Capp A, Gupta S et al (2011) Does the planning dose-volume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerised tomography scans. Radiother Oncol 98(2):162–168
Maggio A, Gabriele D, Garibaldi E et al (2017) Impact of a rectal and bladder preparation protocol on prostate cancer outcome in patients treated with external beam radiotherapy. Strahlenther Onkol 193:722–732
Poortmans P, Bossi A, Vandeputte K, Bosset M, Miralbell R, Maingon P et al (2007) Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiother Oncol 84:121–127
Gay HA, Barthold HJ, O’Meara E et al (2012) Pelvic normal tissue contouring guidelines for radiation therapy: A radiation therapy oncology group consensus panel Atlas. Int J Radiat Oncol Biol Phys 83(3):e353–e362. https://doi.org/10.1016/j.ijrobp.2012.01.02
Marks LB, Yorke ED, Jackson A et al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:10–19
Ghilezan M, Yan D, Liang J, Jaffray D, Wong J, Martinez A (2004) Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys 60:1602–1610
Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO (2010) Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 76:123–129
Diot Q, Olsen C, Kavanagh B, Raben D, Miften M (2011) Dosimetric effect of online image-guided anatomical interventions for postprostatectomy cancer patients. Int J Radiat Oncol Biol Phys 79(2):623–632
Fiorino C, Foppiano F, Franzone P, Broggi S, Castellone P, Marcenaro M, Calandrino R, Sanguineti G (2005) Rectal and bladder motion during conformal radiotherapy after radical prostatectomy. Radiother Oncol 74:187–195
Padhani AR, Khoo VS, Suckling J, Husband JE, Leach MO, Dearnaley DP (1999) Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys 44:525–533
Murthy V, Shukla P, Adurkar P, Master Z, Mahantshetty U, Shrivastava SK (2011) Dose variation during hypofractionated image-guided radiotherapy for prostate cancer: Planned versus delivered. J Cancer Res Ther 7:162–167
Ghadjar P, Zelefsky MJ, Spratt DE et al (2014) Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 88(2):339–344
Frank SJ, Dong L, Kudchadker RJ et al (2008) Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 71(3):813
Orlandini LC, Coppola M, Fulcheri C et al (2017) Dose tracking assessment for image-guided radiotherapy of the prostate bed and the impact on clinical workflow. Radiat Oncol 12:78
de Crevoisier R et al (2018) Daily versus weekly prostate cancer image-guided radiotherapy: Phase 3 multicenter randomized trial. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2018.07.2006
Acknowledgements
We would like to thank the staff who took care of our patients’ needs, and who were involved in gathering, documenting, verifying, forwarding, and processing the clinical data.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
A. Gawish, A.A. Chughtai and M.J. Eble declare that they have no competing interests.
Additional information
Availability of data and materials
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
Authors’ contributions
All authors participated in patient treatment and were involved in the preparation of the manuscript. All authors reviewed and approved the final manuscript.
Rights and permissions
About this article
Cite this article
Gawish, A., Chughtai, A.A. & Eble, M.J. Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy. Strahlenther Onkol 195, 383–392 (2019). https://doi.org/10.1007/s00066-018-1381-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-018-1381-4